AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05066581 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Live Chat
Description: Subjects from the intervention group will be able to ask for a medical intervention if needed with the phisycians from the sleep unit. After the following period, we expect to see better sleep habits in this group when compared to the no intervention one
Study NCT05803863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myatro
Description: myopia control with 0.01% atropine drops
Study NCT05803863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myatro XL
Description: myopia control with 0.05% atropine drops
Study NCT06395675 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ID NOW™
Description: The ID NOW™ CT/NG is an in vitro qualitative molecular assay for the rapid differential.~detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in urine, and self-collected vaginal swabs (SVS) in symptomatic and asymptomatic individuals.
Study NCT05893771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone Injection
Description: Ultrasound-guided genicular nerve block comparing Methylprednisolone combined with Bupivacaine to bupivacaine alone. All patients will undergo TKA and will receive spinal anesthesia.
Study NCT05893771 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hcl 0.5% Inj_#2
Description: Ultasound- guided genicular nerve block using 5 ml bupivacaine 0.5% in 15 ml saline
Study NCT05893771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hcl 0.5% Inj_#2
Description: Ultasound- guided genicular nerve block using 5 ml bupivacaine 0.5% in 15 ml saline
Study NCT05893771 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: normal saline
Description: Ultrasound guided genicular nerve infiltration with 20 ml normal saline as a placebo control.
Study NCT05893771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: normal saline
Description: Ultrasound guided genicular nerve infiltration with 20 ml normal saline as a placebo control.
Study NCT05893771 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: Ultrasound guided genicular nerve infiltration with 20 ml normal saline as a placebo control.
Study NCT05329480 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine Monohydrate
Description: Creatine Monohydrate powder, 4 separate 5g doses per day for 7 days.
Study NCT05329480 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Maltodextrin powder, 4 separate 5g doses per day for 7 days.
Study NCT06605274 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Web-Based Education Program
Description: Before being discharged from the clinic, the women who experienced perinatal loss filled out the Personal Information Form, Perinatal Grief Scale, Edinburgh Postnatal Depression Scale, Beck Hopelessness Scale, and Stress Coping Styles Scale individually. The women were informed about the use of the website. The discharged women were contacted by phone, given the passwords of the birliktegücleniyoruz.com website, and invited to use the website for the five-week education program. Each week, only one session determined for that week was uploaded to the site. Participants who wished to do so were able to watch the uploaded sessions more than once. Retrospective sessions also remained accessible on the site. Each session lasted an average of 20-30 minutes. Women who completed five sessions were contacted by phone in the sixth week. Women filled out the PGS, EPDS, BHS, and SCSS online a second time
Study NCT06605274 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Before being discharged from the perinatology clinic, the women filled out the Personal Information Form, PGS, EPDS, BHS, and SCSS individually. Six weeks after discharge, the participants filled out the same measurement tools online again. During this process, the hospital's routine monitoring continued for the control group. The website was opened to the use of participants who wanted to use the site after the completion of the final tests.
Study NCT06654505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paired Community Health Workers
Description: Community Health Workers will promote maternal and child health services as paired female and male
Study NCT06661967 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine spray
Description: Comparison of the success rate of endotracheal intubations between lidocaine spray and placebo
Study NCT06661967 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lidocaine spray
Description: Comparison of the success rate of endotracheal intubations between lidocaine spray and placebo
Study NCT06660524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevelamer
Description: Sevelamer is administered orally, and the administration strategy is implemented in accordance with the 2017 KDIGO Guideline and the 2019 Chinese Guidelines for the Diagnosis and Treatment of Mineral and Bone Disorders in Chronic Kidney Disease.
Study NCT06660524 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium carbonate
Description: Calcium carbonate is administered orally, and the administration strategy is implemented in accordance with the 2017 KDIGO Guideline and the 2019 Chinese Guideline for the Diagnosis and Treatment of Mineral and Bone Disorders in Chronic Kidney Disease.
Study NCT06661187 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Description: Patients who received cryoanalgesia: patients subjects underwent arterial puncture. patients in the intervention group had a small plastic bag filled with 12 oz of crushed ice applied to the radial artery puncture site for 3 min (timed with a stopwatch) without external compression or massage.
Study NCT06661187 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Psychological instructions
Description: Psychological interventions using verbal signals of the impending procedure, music distraction, visual distraction, and breathing interventions be used during arterial puncture in adults
Study NCT06661187 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Routine care
Description: No intervention deliver routine care
Study NCT06658054 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant analgesia
Description: Patients will receive adjuvant dexmedetomidine (25mcg) and dexamethasone (5mg) in addition to bupivacaine.
Study NCT06658054 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control (Standard treatment)
Description: Patient will receive standard ESPB with bupivacaine and normal saline
Study NCT06659016 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fosfomycin 3 g
Description: Fosfomycin trometamol 3 g administered orally in a single dose every ten days for three months, repeated every three months for a total treatment duration of 12 months.
Study NCT06659016 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Uroxin 4G
Description: Dietary supplement of D-mannose, collagen, hyaluronic acid, chondroitin sulphate, propolis plus quercetin (Proqutin ®) and Bacillus Coagulans (Uroxin 4G, Pharmasuisse laboratories, Milan, Italy) administered twice daily for seven days in the first month, then once daily for 14 days a month for two months, repeated every three months for a total treatment duration of 12 months.
Study NCT06659016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of dietary supplement and fosfomycin
Description: Fosfomycin trometamol 3 g administered orally in a single dose every ten days for three months, repeated every three months for a total treatment duration of 12 months, combined with an oral formulation of D-mannose, collagen, hyaluronic acid, chondroitin sulphate, propolis plus quercetin (Proqutin ®) and Bacillus Coagulans (Uroxin 4G, Pharmasuisse laboratories, Milan, Italy) administered twice daily for seven days in the first month, then once daily for 14 days a month for two months, repeated every three months for a total treatment duration of 12 months.
Study NCT06605820 — intervention group
Intervention type: OTHER
Intervention: None - Interview Only
Description: None - Interview Only
Study NCT04885972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Resiniferatoxin
Description: Resiniferatoxin is a compound purified from natural sources.
Study NCT04885972 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zilretta
Description: Zilretta is an extended-release corticosteroid approved to manage osteoarthritis knee pain.
Study NCT04885972 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vehicle solution
Study NCT06042452 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Genetic
Description: A saliva sample test will be undertaken by all participants in order to analyze their DNA for personalizing their recommendations. The Global Screening Array (GSA) will be used.
Study NCT05322876 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Hearts Family Program
Description: Participants will participate in a baseline health and knowledge screening, followed by a 6-week once-weekly class series, and 3- and 6-month follow-up health and knowledge screenings.
Study NCT06606717 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine Whey Protein
Description: 3 grams creatine + 30 grams whey protein
Study NCT06513520 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sampling
Description: Additional blood tube collection during routine blood sampling.
Study NCT06476483 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: DIALOG+
Description: A person-centred and solution-focused intervention linked to the DIALOG outcome measure (a measure of patient experience and quality of life).
Study NCT06476483 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: DIALOG
Description: An outcome measure consisting of 11 questions, with 8 related to quality of life and 3 items on treatment satisfaction. Patients can rate their satisfaction on a 7-point scale for each of the 8 life domains and 3 treatment aspects, resulting in scores for both quality of life and treatment satisfaction. The DIALOG scale does not provide any guidance for patient and clinician interactions.
Study NCT06606717 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey Protein
Description: 30 grams Whey Protein
Study NCT06607536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: calcium chloride surface treatment in mini implant
Description: 0.1M of Calcium Chloride were used to immersed the orthodontic mini implant
Study NCT06607536 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acid Etched
Description: Mini implant etched in Hydrochloric acid
Study NCT05541666 — intervention group
Intervention type: BEHAVIORAL
Intervention: The Emotional Freedom Technique
Description: The Emotional Freedom Technique (EFT) is a method that uses cognitive functions and physical components (tapping acupuncture points) to bring about psychological changes. The Emotional Freedom Technique is a non-invasive procedure that uses acupuncture meridians. We stimulate these energy points by touching the 14 basic meridian points ın this technique. We make suggestions to our subconscious by repeating the setup sentence for the problem we want to solve. Thus, we try to solve the blockages in the meridians that prevent the flow of energy. Energy blockages disrupt the balance of the mind/body/energy system. This situation causes negative emotions such as stress, panic, fear, and sadness in the person. And with the effect of emotions, disturbances may occur in our physical body. When the energy blockage is removed, the person can feel positive emotions such as happiness, personal power, feeling good, understanding, and loving behavior.
Study NCT06374589 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed-loop FiO2 controller
Description: Close-loop FiO2 controller software option provides automated adjustment of the ventilator Oxygen setting to maintain the patient's SpO2 in a defined target range. When using the software option, the user defines the SpO2 target range, as well as the SpO2 emergency limits, and the device adjusts the FiO2 setting to keep the patient's SpO2 in the target range.
Study NCT06374589 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional
Description: Six hours period where the fraction of inspired oxygen (FiO2) delivered will be manually titrated by clinician based on SpO2 values obtained from the patient.
Study NCT05130268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronedarone
Description: Dronedarone 400 mg twice daily in addition to usual care
Study NCT06607224 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental (Decision making guided by CGM)
Description: Patients use FSL2 and a smartphone. Libreview app will be used to assess interstitial glucose, alarms, and trend arrows, and LibreLinkUp app for research team. Concurrently, CG will be performed using the FreeStyle Optium Neo glucometer from Abbott. The nursing staff will be trained to manage and respond to alarms and trend arrows according to established protocols. The basal insulin adjustment protocol establishes with fasting and premeal targets between 140-180 mg/dL. For prandial insulin, corrective guidelines set according to each patient sensitivity factor, with additional adjustments for the intervention group based on trend arrows. The hypoglycemia alarm sets below 85 mg/dL. If activated, nursing staff will confirm the value via CG. If values are below 70 mg/dL, follow hypoglycemia protocol and if below 100 mg/dL with a descending trend arrow, 15 grams of slow-acting carbs. The hyperglycemia alarm will be set above 300 mg/dL and nurse inform investigators to make decisions.
Study NCT06608680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iTBS
Description: Excitatory stimulation of supramarginal gyrus
Study NCT06608680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cTBS
Description: Inhibitory stimulation to supramarginal gyrus
Study NCT06608680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sham Stimulation
Description: Sham stimulation of supramarginal gyrus
Study NCT06660771 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Functional orthodontic treatment
Description: The patients were treated with Twin block and Herbst functional appliances. Alginate impressions and a protrusive wax bite were taken for the construction of each appliance. Each device was fitted and then reviewed 4-6 weeks later. First group was treated with Twin block which was manufactured basically according to the original design described by Clark. The overjet was measured from the patients in centric relationship and maximum protrusion position, and construction bite was recorded with 70% of the total advancement capacity of the mandible and 2-4 mm above the freeway space vertically. Overjet measurements were made at each session and active treatment was terminated when a normal overjet in the retracted position was recorded.~Second group was treated with the stainless-steel crown Herbst appliance, included crowned maxillary first molars and mandibular first premolars. The construction bite was recorded with the mandible forward by edge-to-edge incisor position.
Study NCT05006547 — intervention group
Intervention type: OTHER
Intervention: Electromyograph Biofeedback training of the peroneal muscle
Description: The exercise will be performed with the subject sitting in front of a computer monitor, on an elevated chair, and his feet will be in the air. The examiner will ask the subject to perform a maximum contraction of the paronal muscles, in an open kinematic chain. After reference, the subject will begin a five-minute practice. The practice will be divided into rounds of: eight seconds of muscle work and 15 seconds rest.
Study NCT05287256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Delta-8-THC Cannabis
Description: Delta-8-THC cannabis will be orally self-administered by study participants
Study NCT05287256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Delta-9-THC Cannabis
Description: Delta-9-THC cannabis will be orally self-administered by study participants
Study NCT05287256 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Placebo
Description: Placebo will be orally self-administered by study participants
Study NCT05287256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaporized Delta-8-THC Cannabis
Description: Delta-8-THC cannabis will be self-administered by study participants using a vaporizer
Study NCT05287256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaporized Delta-9-THC Cannabis
Description: Delta-9-THC cannabis will be self-administered by study participants using a vaporizer
Study NCT05287256 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vaporized Placebo
Description: Placebo will be self-administered by study participants using a vaporizer
Study NCT05918406 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Nasal Guide
Description: Use of Nasal Guide with administration of Tyrvaya (varenicline solution 0.03 mg) BID
Study NCT06056258 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: VL-NL-02
Description: Two capsules to be taken 45±10 mins before sleep (after dinner) for 21 days
Study NCT06056258 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two capsules to be taken 45±10 mins before sleep (after dinner) for 21 days
Study NCT05868421 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support Person Coaching Call
Description: Support person participants assigned to the intervention group will additionally receive a 1-call coaching session about 15-25 minutes in duration on how to support their Veteran smoker. The session will be delivered by research staff by phone or video call. Support persons in the intervention group and the control/no intervention group will receive existing written material resources on support strategies to stop smoking, and resources on how to stop smoking by postal mail or email.
Study NCT05868421 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SP written materials
Description: Written materials covering tips on effective supportive strategies for smoking cessation
Study NCT05868421 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SP written materials
Description: Written materials covering tips on effective supportive strategies for smoking cessation
Study NCT05868421 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Written Smoking Cessation Materials
Description: Written materials on resource and referral information for VHA and non-VHA EBCT options
Study NCT05868421 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Written Smoking Cessation Materials
Description: Written materials on resource and referral information for VHA and non-VHA EBCT options
Study NCT04417166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 50 mg powder for concentrate for solution for infusion
Study NCT04417166 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Involved Field Radiation Therapy
Description: 50-54 Gy Involved Field Radiation Therapy (IFRT) as proposed by the International Lymphoma Radiation Oncology Group (ILROG) guidelines. 50 Gy is recommended in patients without primary tumor invasiveness (invasion to adjacent tissue and/or organs), 54 Gy in locally advanced cases (invasion to adjacent tissue and/or organs) or with other risk factors (age > 60 years, stage II, elevated serum LDH levels).~Intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) are recommended but not mandatory; 3-dimensional conformal RT (3D-CRT) is allowed.
Study NCT06653036 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dural puncture epidural
Description: The Dural puncture epidural technique is done by assessing the epidural space using the Touhy needle and puncturing the dura matter with a finer needle.
Study NCT06653036 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Epidural Technique
Description: The Standard Epidural Technique is usually performed by identifying the epidural space using the loss of resistance technique and threading the epidural catheter in the epidural space for administration of analgesic drugs.
Study NCT05562557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement
Description: To encourage intrinsic motivation to engage in fatherhood activities
Study NCT05562557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERO Dads Fatherhood Program
Description: Fatherhood engagement curriculum to increase awareness, knowledge, and skills for parenting and co-parenting
Study NCT05562557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management
Description: To reinforce healthy behaviors, including attendance at services
Study NCT05372731 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver
Description: RM after BAL
Study NCT05472675 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Botulinum toxin and bupivacain
Description: Botulinum toxin A AND bupivacain( local anesthetic)
Study NCT04074018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-rehabilitation program
Description: facial self-rehabilitation for a duration of 6 months
Study NCT04074018 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation program
Description: Conventional facial rehabilitation for a duration of 6 months
Study NCT04809818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LT3001 drug product
Description: Multiple doses of LT3001 drug product administered by intravenous infusion